Novavax NVAX EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Novavax’s reported figures.
Based on trailing twelve months.
The official record: Novavax’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Novavax's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Novavax's EBITDA margin?
- Novavax (NVAX) reported EBITDA margin of -9.4% in Q1 2026.
- How has Novavax's EBITDA margin changed year-over-year?
- Novavax's EBITDA margin decreased by 125.8% year-over-year, from 36.3% to -9.4%.
- What is the long-term trend for Novavax's EBITDA margin?
- Over 4 years (2021 to 2025), Novavax's EBITDA margin has grown at a -26.4% compound annual growth rate (CAGR), from -146% to 42.8%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.